{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:21:59Z","timestamp":1792110119940,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4651,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.fertnstert.2009.03.113","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T04:08:50Z","timestamp":1248667730000},"page":"1025-1038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":222,"title":["Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile"],"prefix":"10.1016","volume":"92","clinical-trial-number":[{"clinical-trial-number":"nct00675688","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Rogerio A.","family":"Lobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn V.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margery L.S.","family":"Gass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine H.","family":"Dorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Ronkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Pickar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger","family":"Constantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.03.113_bib1","unstructured":"Population Division U.S. Census Bureau. Table 1: Annual estimates of the population by sex and five-year age groups for the United States: April 1, 2000 to July 1, 2007. NC-EST2007\u201301. May 2008."},{"key":"10.1016\/j.fertnstert.2009.03.113_bib2","first-page":"1","article-title":"Should symptomatic menopausal women be offered hormone therapy?","volume":"8","author":"Lobo","year":"2006","journal-title":"Med Gen Med"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib3","unstructured":"National Osteoporosis Foundation. Fast Facts. Available at http:\/\/www.nof.org\/osteoporosis\/diseasefacts.htm. Accessed January 29, 2007."},{"key":"10.1016\/j.fertnstert.2009.03.113_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","article-title":"Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study","volume":"23","author":"Miller","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib5","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo- and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib6","first-page":"1086","article-title":"Bazedoxifene (Wyeth)","volume":"5","author":"Gruber","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib7","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/en.2005-0030","article-title":"Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity","volume":"146","author":"Komm","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.AOG.0000163253.27610.b9","article-title":"Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women","volume":"105","author":"Ronkin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1358\/dof.2002.027.02.637843","article-title":"Bazedoxifene acetate","volume":"27","author":"Miller","year":"2002","journal-title":"Drugs Future"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib10","first-page":"S14","article-title":"Effects of bazeoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on the incidence of breast pain","volume":"14","author":"Boudes","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib11","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.fertnstert.2006.07.236","article-title":"Bazedoxifene combined with conjugated estrogens: a novel alternative to traditional home therapies","volume":"86","author":"Van Duren","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex (TSEC) of bazedoxifene\/conjugated estrogens (BZA\/CE) for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2009.05.093","article-title":"Bazedoxifene\/conjugated estrogens (BZA\/CE): incidence of uterine bleeding in postmenopausal women","volume":"92","author":"Archer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2362.1993.tb00792.x","article-title":"The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women","volume":"23","author":"Walton","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/09513599709152559","article-title":"Is there a menopausal metabolic syndrome?","volume":"11","author":"Spencer","year":"1997","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/0002-9378(88)90194-9","article-title":"Lipids, clotting factors, and diabetes: endogenous risk factors for cardiovascular disease","volume":"158","author":"Lobo","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib18","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1161\/01.CIR.99.18.2480","article-title":"Guide to preventive cardiology for women. AHA\/ACC Scientific Statement Consensus Panel statement","volume":"99","author":"Mosca","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/1047-2797(92)90051-Q","article-title":"Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop","volume":"2","author":"Manolio","year":"1992","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib20","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/archinte.1993.00410190045006","article-title":"Plasma lipoprotein levels as predictors of cardiovascular death in women","volume":"153","author":"Bass","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib21","first-page":"987","article-title":"Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group","volume":"84","author":"Lobo","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"273","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(01)01829-5","article-title":"Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism","volume":"76","author":"Lobo","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.113_bib24","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.283.14.1845","article-title":"Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause","volume":"283","author":"Shlipak","year":"2000","journal-title":"J Am Med Assoc"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209013077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209013077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:31:55Z","timestamp":1777296715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209013077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0015028209013077"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.113","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}